GO:0009156 ribonucleoside monophosphate biosynthetic process: Nucleotide Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009156 describes the set of biochemical reactions that build ribonucleoside monophosphates, the basic building blocks of RNA and many coenzymes.
• The pathway supplies AMP, GMP, CMP and UMP, which are required for RNA synthesis, energy transfer and signaling.
• Enzymes such as adenosine kinase (ADK) and ADAL regulate the levels of modified adenosine monophosphates and protect metabolism.
• Inhibition of ribonucleoside monophosphate biosynthesis is a validated antiviral strategy, as shown for SARS-CoV-2 proofreading and HCV inhibitors.
• Dysregulation of this pathway is linked to cancer, viral infections and immune disorders, making it a target for therapeutic intervention.
• CRISPR knockout, point mutation, knock-in and overexpression models enable precise dissection of each enzymatic step in this process.
Description
Ribonucleoside monophosphate biosynthetic process (GO:0009156) is the biological process that generates ribonucleoside monophosphates, which are compounds consisting of a nucleobase linked to a ribose sugar esterified with phosphate on the sugar. These molecules are the monomeric units of RNA and serve as precursors for energy carriers and signaling molecules. Understanding this process is fundamental for researchers studying nucleic acid metabolism, antiviral drug development and cancer biology. The pathway is highly conserved and involves both de novo synthesis and salvage reactions that recycle nucleosides. Recent studies have highlighted the role of metal/ADP complexes in promoting phosphorylation of ribonucleotides, suggesting ancient abiotic routes that may inform prebiotic chemistry. In cells, the balance of ribonucleoside monophosphates is tightly regulated to prevent metabolic stress and to support rapid proliferation.
ribonucleoside monophosphate biosynthetic process At A Glance
| GO ID | GO:0009156 |
|---|---|
| GO term | ribonucleoside monophosphate biosynthetic process |
| Ontology | biological_process |
| Synonym | ribonucleoside monophosphate anabolism, ribonucleoside monophosphate biosynthesis, ribonucleoside monophosphate formation, ribonucleoside monophosphate synthesis |
| Major function | Production of AMP, GMP, CMP and UMP for RNA synthesis and cellular metabolism |
| Key enzymes | Adenosine kinase (ADK), ADAL, purine and pyrimidine biosynthetic enzymes |
| Pathway type | Anabolic, both de novo and salvage |
| Cellular location | Cytoplasm and mitochondria |
| Related diseases | Cancer, viral infections, immune disorders |
What Is GO:0009156?
GO:0009156 encompasses the chemical reactions and pathways that result in the formation of a ribonucleoside monophosphate, a molecule composed of a nitrogenous base attached to a ribose sugar that carries a phosphate group on the sugar. This process includes both the de novo assembly of the purine and pyrimidine rings and the salvage pathways that convert nucleosides to their corresponding monophosphates.
Why Is ribonucleoside monophosphate biosynthetic process Important in Cell Biology?
Ribonucleoside monophosphate biosynthesis is essential for all living cells because it provides the building blocks for RNA and supplies precursors for DNA, coenzymes and signaling molecules. Disruption of this pathway leads to impaired cell proliferation and increased susceptibility to viral infections, as viruses rely on host nucleotide pools for replication. Moreover, enzymes in this pathway are targets for immunosuppressive and antiviral drugs, such as mizoribine, which inhibits IMP dehydrogenase. Understanding the regulation of this process is therefore critical for developing therapies against cancer and infectious diseases.
• Provides the four ribonucleoside monophosphates (AMP, GMP, CMP, UMP) required for RNA synthesis.
• Supplies precursors for DNA synthesis after reduction to deoxyribonucleotides.
• Maintains cellular energy balance through ATP and GTP production.
• Supports signaling pathways via cyclic AMP and cyclic GMP.
• Enables rapid proliferation of immune cells and cancer cells.
• Is a target for antiviral drugs against HCV and SARS-CoV-2.
• Is modulated by immunosuppressants like mizoribine.
• Influences adenosine-mediated immune regulation.
• Can be studied using abiotic synthesis models to understand origins of life.
• Dysregulation contributes to metabolic disorders and neurodegeneration.
What Happens During ribonucleoside monophosphate biosynthetic process?
De novo purine biosynthesis
In simple terms: The cell builds the purine ring from scratch using small molecules.
The de novo purine pathway converts 5-phosphoribosyl-1-pyrophosphate (PRPP) into inosine monophosphate (IMP) through a series of ten enzymatic steps. IMP is then converted to AMP and GMP by specific branch pathways. This process requires energy and is tightly regulated to match cellular demand.
De novo pyrimidine biosynthesis
In simple terms: The cell assembles the pyrimidine ring and attaches it to ribose phosphate.
Pyrimidine biosynthesis begins with the formation of carbamoyl phosphate and proceeds to uridine monophosphate (UMP), which is subsequently phosphorylated to UTP and CTP. The pathway is regulated by feedback inhibition and is essential for RNA and DNA synthesis.
Salvage pathways
In simple terms: The cell recycles nucleosides from degraded RNA or extracellular sources.
Salvage enzymes such as adenosine kinase (ADK) phosphorylate nucleosides to their monophosphates, conserving energy. ADAL coordinates the detoxification of modified adenosines, preventing accumulation of toxic intermediates. These pathways are critical for maintaining nucleotide pools under stress.
Phosphorylation of ribonucleotides by metal/ADP complexes
In simple terms: Metal ions and ADP can chemically promote the addition of phosphate to ribonucleosides.
Recent studies show that metal/ADP complexes can catalyze the phosphorylation of ribonucleotides under prebiotic conditions, suggesting a possible abiotic origin for this process. This mechanism may also occur in modern cells under specific conditions.
Aqueous microdroplet-driven synthesis
In simple terms: Water microdroplets can accelerate the formation of ribonucleotides.
Aqueous microdroplets have been shown to drive the abiotic synthesis of ribonucleotides, providing insights into how these molecules might have formed on early Earth. This highlights the robustness of ribonucleoside monophosphate biosynthesis across different environments.
Key Genes Involved in GO:0009156 ribonucleoside monophosphate biosynthetic process
The following genes and proteins are key players in ribonucleoside monophosphate biosynthetic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADK | Phosphorylates adenosine to AMP | Regulates adenosine levels and immune response |
| ADAL | Detoxifies modified adenosines | Prevents metabolic stress |
| IMPDH1 | Converts IMP to XMP in GMP synthesis | Target of immunosuppressants |
| IMPDH2 | Converts IMP to XMP in GMP synthesis | Target of immunosuppressants |
| GMPS | Converts XMP to GMP | Essential for GMP production |
| ADSS | Converts IMP to adenylosuccinate | Required for AMP synthesis |
| ADSL | Cleaves adenylosuccinate to AMP | Defects cause adenylosuccinate lyase deficiency |
| ATIC | Bifunctional enzyme in purine synthesis | Catalyzes two steps in IMP synthesis |
| GART | Phosphoribosylglycinamide formyltransferase | Involved in purine de novo synthesis |
| PFAS | Phosphoribosylformylglycinamidine synthase | Purine biosynthesis |
| PAICS | Phosphoribosylaminoimidazole carboxylase | Purine biosynthesis |
| CAD | Multifunctional enzyme for pyrimidine synthesis | Catalyzes first three steps of UMP synthesis |
| UMPS | Converts orotate to UMP | Essential for pyrimidine synthesis |
| CTPS1 | Converts UTP to CTP | Required for CTP production |
| NME1 | Nucleoside diphosphate kinase | Maintains nucleotide pools |
| PRPS1 | Synthesizes PRPP | Rate-limiting for purine synthesis |
| HPRT1 | Salvage enzyme for hypoxanthine | Deficiency causes Lesch-Nyhan syndrome |
How Is ribonucleoside monophosphate biosynthetic process Regulated?
Ribonucleoside monophosphate biosynthesis is regulated at multiple levels. Feedback inhibition by end products (AMP, GMP, UMP) controls the activity of key enzymes such as IMP dehydrogenase and CAD. Transcriptional regulation responds to growth signals and nutrient availability. Adenosine kinase and ADAL are regulated by metabolic stress and inflammatory signals. Additionally, the process is influenced by the availability of PRPP and energy charge.
ribonucleoside monophosphate biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADK | Immune dysregulation, cancer | Knockout mice, cell lines |
| ADAL | Metabolic stress, neurodegeneration | Point mutation knock-in |
| IMPDH1/2 | Cancer, viral infections | Overexpression, CRISPR KO |
| HPRT1 | Lesch-Nyhan syndrome | HPRT1 knockout cells |
| UMPS | Orotic aciduria | Knock-in of patient mutations |
Cancer
Cancer cells often upregulate ribonucleoside monophosphate biosynthesis to support rapid proliferation. Inhibitors of IMP dehydrogenase, such as mizoribine, show anti-tumor activity. Targeting this pathway is a promising therapeutic strategy.
Viral infections
Viruses depend on host nucleotide pools for replication. SARS-CoV-2 proofreading and HCV inhibitors highlight the importance of targeting ribonucleotide biosynthesis. Drugs like remdesivir mimic ribonucleoside monophosphates to block viral RNA polymerase.
Immune disorders
Adenosine signaling, regulated by ADK and ADAL, modulates immune responses. Dysregulation can lead to autoimmune diseases and immunodeficiency.
Metabolic and neurological disorders
Defects in purine salvage enzymes like HPRT1 cause Lesch-Nyhan syndrome, a neurological disorder. ADAL deficiency leads to accumulation of toxic adenosine metabolites.
From ribonucleoside monophosphate biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ADK loss affect adenosine monophosphate levels? | ADK knockout cell line |
| How do point mutations in IMPDH2 alter drug resistance? | Point mutation knock-in |
| Can overexpression of CAD increase pyrimidine synthesis? | Overexpression cell model |
| What is the role of ADAL in detoxification? | ADAL knockout and tagged knock-in |
| Does HPRT1 deficiency cause metabolic rewiring? | HPRT1 knockout iPSCs |
| Can CRISPR library screening identify synthetic lethal partners? | Genome-wide CRISPR knockout library |
How to Study the ribonucleoside monophosphate biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Nucleotide levels | Drug response, pathway flux |
| RNA-seq | Gene expression | Transcriptional regulation |
| CRISPR knockout screening | Gene essentiality | Identify synthetic lethal targets |
| Enzyme activity assay | Catalytic rate | Characterize mutants |
| Western blot | Protein expression | Validate knockout/overexpression |
| Immunofluorescence | Subcellular localization | Study enzyme localization |
| Ribo-seq | Translation efficiency | Assess codon usage effects |
Metabolomics
Mass spectrometry-based metabolomics quantifies intracellular levels of ribonucleoside monophosphates and their precursors. This method is essential for assessing pathway activity and drug effects.
RNA sequencing (RNA-seq)
RNA-seq measures transcript levels of genes involved in ribonucleoside monophosphate biosynthesis, revealing transcriptional regulation.
CRISPR screening
Genome-wide CRISPR knockout screens identify genes required for cell growth under conditions that challenge nucleotide synthesis.
Enzymatic assays
In vitro enzymatic assays using recombinant enzymes measure catalytic activity of individual steps, such as ADK or IMPDH.
How CRISPR Can Be Used to Study GO:0009156 ribonucleoside monophosphate biosynthetic process
Knockout
CRISPR knockout of genes such as ADK or IMPDH depletes specific enzymatic activities, allowing researchers to study their roles in ribonucleoside monophosphate biosynthesis and cellular phenotypes.
Point Mutation
Point mutations introduced by CRISPR base editing or HDR can mimic patient variants in enzymes like UMPS or HPRT1, revealing how single amino acid changes affect pathway function.
Knock-in
Knock-in of tagged versions of enzymes (e.g., GFP-ADAL) enables live-cell imaging and proteomic analysis of the pathway.
Overexpression
Overexpression of rate-limiting enzymes like PRPS1 or CAD boosts flux through the pathway, useful for studying metabolic burden and drug resistance.
How EDITGENE Supports ribonucleoside monophosphate biosynthetic process Research
Researchers studying ribonucleoside monophosphate biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease progression or drug response. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for ribonucleoside monophosphate biosynthetic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PRPS1 Knockout HEK293 Cell Line | EDJ-KQ2295 | Human | 5631 | Details Get a Quote |
| ADK Knockout HEK293 Cell Line | EDJ-KQ3783 | Human | 132 | Details Get a Quote |
| PRPS2 Knockout HEK293 Cell Line | EDJ-KQ5548 | Human | 5634 | Details Get a Quote |
| PRPS1L1 Knockout HEK293 Cell Line | EDJ-KQ8127 | Human | 221823 | Details Get a Quote |
| PRPS1 Knockout HCT 116 Cell Line | EDJ-KQ21331 | Human | 5631 | Details Get a Quote |
| PRPS1 Knockout A-549 Cell Line | EDJ-KQ22659 | Human | 5631 | Details Get a Quote |
| PRPS1 Knockout HeLa Cell Line | EDJ-KQ22661 | Human | 5631 | Details Get a Quote |
| ADK Knockout A-549 Cell Line | EDJ-KQ25879 | Human | 132 | Details Get a Quote |
| ADK Knockout HCT 116 Cell Line | EDJ-KQ25880 | Human | 132 | Details Get a Quote |
| ADK Knockout HeLa Cell Line | EDJ-KQ25881 | Human | 132 | Details Get a Quote |
| PRPS2 Knockout A-549 Cell Line | EDJ-KQ28807 | Human | 5634 | Details Get a Quote |
| PRPS2 Knockout HCT 116 Cell Line | EDJ-KQ28808 | Human | 5634 | Details Get a Quote |
| PRPS2 Knockout HeLa Cell Line | EDJ-KQ28809 | Human | 5634 | Details Get a Quote |
| PRPS1L1 Knockout HeLa Cell Line | EDJ-KQ59177 | Human | 221823 | Details Get a Quote |
| PRPS1L1 Knockout A-549 Cell Line | EDJ-KQ67648 | Human | 221823 | Details Get a Quote |
Displaying Records 1 To 15 Of 16 Records
Frequently Asked Questions About ribonucleoside monophosphate biosynthetic process
What is ribonucleoside monophosphate biosynthetic process?
It is the set of biochemical reactions that produce ribonucleoside monophosphates, the building blocks of RNA, as defined by GO:0009156.
What genes are involved in ribonucleoside monophosphate biosynthetic process?
Key genes include ADK, ADAL, IMPDH1, IMPDH2, GMPS, ADSS, ADSL, ATIC, GART, PFAS, PAICS, CAD, UMPS, CTPS1, NME1, PRPS1 and HPRT1.
Why is ribonucleoside monophosphate biosynthesis important for cancer?
Cancer cells upregulate this pathway to support rapid proliferation, making it a therapeutic target.
How do viruses hijack ribonucleoside monophosphate biosynthesis?
Viruses rely on host nucleotide pools for replication; drugs like remdesivir mimic ribonucleoside monophosphates to inhibit viral polymerases.
What diseases are linked to defects in this pathway?
Defects cause Lesch-Nyhan syndrome, orotic aciduria, immune disorders and metabolic stress.
What methods are used to study ribonucleoside monophosphate biosynthesis?
Metabolomics, RNA-seq, CRISPR screening, enzymatic assays and imaging are commonly used.
How can CRISPR help study this pathway?
CRISPR knockout, point mutation, knock-in and overexpression models allow precise manipulation of pathway genes.
What is the role of adenosine kinase in this process?
Adenosine kinase phosphorylates adenosine to AMP, regulating adenosine levels and immune responses.
Can ribonucleoside monophosphates be synthesized abiotically?
Yes, metal/ADP complexes and aqueous microdroplets can promote their formation under prebiotic conditions.
What is the connection between ribonucleoside monophosphate biosynthesis and immunosuppression?
Drugs like mizoribine inhibit IMP dehydrogenase, blocking GMP synthesis and suppressing immune cell proliferation.
Conclusion
Ribonucleoside monophosphate biosynthetic process (GO:0009156) is a central metabolic pathway that supplies the building blocks for RNA and DNA, and its dysregulation is implicated in cancer, viral infections and immune disorders. Understanding the enzymes and regulatory mechanisms involved provides opportunities for therapeutic intervention. CRISPR-based models are invaluable for dissecting the function of individual genes in this pathway. EDITGENE offers comprehensive services to accelerate research in this field.
References
- 1. Ogawa A et al.. 2025. Adenosine kinase and ADAL coordinate detoxification of modified adenosines to safeguard metabolism.. Cell 188(22):6151-6169.e24 PMID: 40840445
- 3. Kondo H et al.. 2005. [Mizoribine].. Nihon Rinsho 63 Suppl 5:708-12 PMID: 15954433
- 4. Robson F et al.. 2020. Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting.. Mol Cell 79(5):710-727 PMID: 32853546
- 5. Dolezal T. 2015. Adenosine: a selfish-immunity signal?. Oncotarget 6(32):32307-8 PMID: 26427038
- 6. Werner E et al.. 2023. Metal/ADP Complexes Promote Phosphorylation of Ribonucleotides.. J Am Chem Soc 145(39):21630-21637 PMID: 37750669
- 7. Elfiky AA. 2020. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.. Life Sci 248:117477 PMID: 32119961
- 8. Ju Y et al.. 2022. Aqueous-Microdroplet-Driven Abiotic Synthesis of Ribonucleotides.. J Phys Chem Lett 13(2):567-573 PMID: 35014840
